Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Inflammation stories

Apr 6, 2026

Scripps Research Develops New Anti-Inflammatory Drug Class That Preserves Immune Function

Scripps Research scientists have developed a first-in-class drug compound that reduces harmful inflammation while leaving the body's ability to fight infections intact, addressing a long-sought goal in treating autoimmune diseases.

Apr 6, 2026·1 source
00

Top claims

  • ▪ENDOtollins could improve quality of life for autoimmune disease patients by reducing treatment-related infection risks
  • ▪Current autoimmune disease treatments force patients to choose between managing inflammation and maintaining infection resistance
  • ▪ENDOtollins work by interrupting a molecular handshake between two proteins inside immune cells

Topics

Biomarkers & bloodwork testingInflammation reduction & immune effectsDrug Approval and Clinical Trials

Related entities

LupusAutoimmune diseaseImmunologyRheumatoid arthritis